Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06477302 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer

Study acronym: STA-RR-LC
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 23, 2025 (before its estimated June 23, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jun 23, 2025 to Jun 23, 2026
    • Study completion date: Jun 23, 2026 to Jun 23, 2027
    • Site details revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this non experimental, transversal instrument study is to Construct and determine the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer in Mexican patients with a lung cancer diagnosis. The main question it aims to answer is: What is the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer of the patients with this diagnosis that are currently undergoing an assessment or follow up program of Respiratory Rehabilitation? The Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC) will be psychometrically valid and reliable for the evaluation of therapeutic adherence on patients with lung cancer that are undergoing an assessment or follow up of Respiratory Rehabilitation.Participants will be asked to fill out an Identification card and fill out the fifty-six items presented on the STA-RR-LC.
Trial Details
NCT Number NCT06477302
Lead Sponsor Instituto Nacional de Cancerologia de Mexico
Conditions
(from sponsor)		 Lung Cancer
Related terms Lung Neoplasms, Treatment Adherence and Compliance
Enrollment 281 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov